PN
Therapeutic Areas
Emercell Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NK-001 (OT-C001) | Cancer (in combination with monoclonal antibodies, e.g., Rituximab) | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| NK-001 (OT-C001) | Cancer (in combination with monoclonal antibodies, e.g., Rituximab) | Phase 1 |